The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shperling N.V.

Institute of military medicine of Defense Ministry of the Russian Federation;
Medical University «Reaviz»

Shperling I.A.

Institute of military medicine of Defense Ministry of the Russian Federation

Chaplygin A.V.

North-Western State Medical University named aft er I.I. Mechnikov

Ustinov M.V.

nd Consultative and Diagnostic Center of the Russian Defense Ministry

Topical drugs for acne treatment

Authors:

Shperling N.V., Shperling I.A., Chaplygin A.V., Ustinov M.V.

More about the authors

Read: 5629 times


To cite this article:

Shperling NV, Shperling IA, Chaplygin AV, Ustinov MV. Topical drugs for acne treatment. Russian Journal of Clinical Dermatology and Venereology. 2021;20(6):66‑70. (In Russ.)
https://doi.org/10.17116/klinderma20212006166

Recommended articles:
The role of azelaic acid in rosa­cea therapy. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):349-357
Study of the role of inte­rleukin-1β in blood serum in patients with acne. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):421-424
Adhe­rence of patients to acne therapy using systemic isotretinoin. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):483-488
Clinical discussion of patients with follicular occlusion syndrome and como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):596-603
Rational choice of combined therapy of acne: systemic isotretinoin and high-energy hardware technologies. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):651-656

References:

  1. Federal clinical guidelines. Dermatovenerology. 2015: Skin diseases. Sexually transmitted infections. 5th ed., reprint. and additional M.: Business Express; 2016. (In Russ.).
  2. Bez Y, Yesilova Y, Kaya MC, Sir A. High social phobia frequency and related disability in patients with acne vulgaris. Eur J Dermatol. 2011;21(5):756-760.  https://doi.org/10.1684/ejd.2011.1418
  3. Muzychenko AP. Topical products of the Stop AKN line (BABE laboratory, Spain) in the treatment of mild and moderate forms of acne. Medical news. 2018;9:58-62. (In Russ.).
  4. Pochi PE, Shalita AR, Strauss JS, Webster SB, Cunliffe WJ, Katz HI, Kligman AM, Leyden JJ, Lookingbill DP, Plewig G, Reisner RM, Rodman OGJr, Turner ML, Webster GF. Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24 and 25, 1990. J Am Acad Dermatol. 1991;24(3):495-500.  https://doi.org/10.1016/s0190-9622(08)80076-x
  5. Nast A, Dréno B, Bettoli V, Bukvic MZ, Degitz K, Dressler C, Finlay AY, Haedersdal M, Lambert J, Layton A, Lomholt HB, López-Estebaranz JL, Ochsendorf F, Oprica C, Rosumeck S, Simonart T, Werner RN, Gollnick H. European evidence-based (S3) guideline for the treatment of acne — update 2016 — short version. J Eur Acad Dermatol Venereol. 2016;30(8):1261-1268. https://doi.org/10.1111/jdv.13776
  6. Dessinioti C, Dreno B. Acne. AD. Katsambas et al. (eds.). European Handbook of Dermatological Treatments. Springer-Verlag Berlin: Heidelberg; 2015;3-18.  https://doi.org/10.1007/978-3-662-45139-7_1
  7. Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, Bowe WP, Graber EM, Harper JC, Kang S, Keri JE, Leyden JJ, Reynolds RV, Silverberg NB, Stein Gold LF, Tollefson MM, Weiss JS, Dolan NC, Sagan AA, Stern M, Boyer KM, Bhushan R. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973.  https://doi.org/10.1016/j.jaad.2015.12.037
  8. Fluhr JW, Degitz K. Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy. J Dtsch Dermatol Ges. 2010;3(8)(suppl 1):24-30.  https://doi.org/10.1111/j.1610-0387.2009.07169.x
  9. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) — a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3): 210-216.  https://doi.org/10.1111/j.1365-2230.1994.tb01167.x

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.